Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncology

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    October 2018
  1. HAYASHI K, Mitani S, Taniguchi H, Yasui H, et al
    Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
    Oncology. 2018 Oct 25:1-8. doi: 10.1159/000493321.
    PubMed     Text format     Abstract available


    August 2018
  2. WILLIS D, Samalin E, Satge D
    Colorectal Cancer in People with Intellectual Disabilities.
    Oncology. 2018 Aug 31:1-14. doi: 10.1159/000492077.
    PubMed     Text format     Abstract available


  3. OKADA K, Sadahiro S, Chan LF, Ogimi T, et al
    The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer.
    Oncology. 2018 Aug 23:1-9. doi: 10.1159/000491019.
    PubMed     Text format     Abstract available


  4. SANTASUSAGNA S, Moreno I, Navarro A, Martinez Rodenas F, et al
    Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients.
    Oncology. 2018 Aug 23:1-10. doi: 10.1159/000490726.
    PubMed     Text format     Abstract available


  5. ITO N, Kawahira H, Nakashima H, Uesato M, et al
    Endoscopic Diagnostic Support System for cT1b Colorectal Cancer Using Deep Learning.
    Oncology. 2018 Aug 21:1-7. doi: 10.1159/000491636.
    PubMed     Text format     Abstract available


    July 2018
  6. SEKINE K, Hamaguchi T, Shoji H, Takashima A, et al
    Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.
    Oncology. 2018 Jul 20:1-9. doi: 10.1159/000489665.
    PubMed     Text format     Abstract available


    March 2018
  7. TANIOKA H, Miyamoto Y, Tsuji A, Asayama M, et al
    Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
    Oncology. 2018 Mar 7. pii: 000486624. doi: 10.1159/000486624.
    PubMed     Text format     Abstract available


    January 2018
  8. PETRELLI F, Ardito R, Ghidini A, Zaniboni A, et al
    Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.
    Oncology. 2018 Jan 23. pii: 000486338. doi: 10.1159/000486338.
    PubMed     Text format     Abstract available


  9. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.
    Oncology. 2018;94:167-175.
    PubMed     Text format     Abstract available


  10. DE FELICE F, Martinetti MT, Orelli S, Bulzonetti N, et al
    Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints.
    Oncology. 2018;94:25-30.
    PubMed     Text format     Abstract available


  11. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
    Oncology. 2018;95:211-219.
    PubMed     Text format     Abstract available


  12. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.
    Oncology. 2018;95:246-250.
    PubMed     Text format     Abstract available


  13. TOIYAMA Y, Oki S, Okugawa Y, Ide S, et al
    Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Oncology. 2018;95:270-280.
    PubMed     Text format     Abstract available


    January 2017
  14. DELHORME JB, Severac F, Waissi W, Romain B, et al
    Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
    Oncology. 2017;93:183-190.
    PubMed     Text format     Abstract available


  15. YAMADA M, Sakurai T, Komeda Y, Nagai T, et al
    Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease.
    Oncology. 2017;93 Suppl 1:20-26.
    PubMed     Text format     Abstract available


  16. OGAWA S, Ishii T, Minaga K, Nakatani Y, et al
    The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal Cancers.
    Oncology. 2017;93 Suppl 1:43-48.
    PubMed     Text format     Abstract available


  17. SAKURAI T, Adachi T, Kono M, Arizumi T, et al
    Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy.
    Oncology. 2017;93 Suppl 1:27-29.
    PubMed     Text format     Abstract available


  18. KOMEDA Y, Kashida H, Sakurai T, Asakuma Y, et al
    Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification.
    Oncology. 2017;93 Suppl 1:49-54.
    PubMed     Text format     Abstract available


  19. OKAMOTO K, Watanabe T, Komeda Y, Kono T, et al
    Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors.
    Oncology. 2017;93 Suppl 1:35-42.
    PubMed     Text format     Abstract available


  20. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Oncology. 2017;93:287-294.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: